Using a QbD approach in the development and formulation of topical products will enable the drug developer to provide a robust control strategy for manufacturing.
Christopher Harrison
Advertisement
Christopher Harrison, is head of Process Development and Manufacture at MedPharm.
Articles by Christopher Harrison
Using a QbD approach in the development and formulation of topical products will enable the drug developer to provide a robust control strategy for manufacturing.
Advertisement
Latest Updated Articles
QbD Strategies to Secure the Scale-Up of Semi-Solid Topical FormulationsPublished: September 2nd 2018 | Updated:
Process Development Best Practices for Topical Drug ProductsPublished: February 2nd 2019 | Updated:
Advertisement
Advertisement
